News | X-Ray | March 29, 2019

Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers

New algorithm identifies manufacturer of pacemaker with 99 percent accuracy, compared to 72 percent for traditional methods

Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers

March 29, 2019 — A research team from Imperial College London believes a new software could speed up the diagnosis and treatment of patients with faulty cardiac rhythm devices in an emergency setting. The software has been able to identify the make and model of different devices, such as pacemakers and defibrillators, within seconds.

The study, published in JACC: Clinical Electrophysiology,1 took place at Hammersmith Hospital, part of Imperial College Healthcare NHS Trust.

James Howard, Ph.D., clinical research fellow at Imperial College London and lead author of the study, said: "Pacemakers and defibrillators have improved the lives of millions of patients from around the world. However, in some rare cases these devices can fail and patients can deteriorate as a result. In these situations, clinicians must quickly identify the type of device a patient has so they can provide treatment such as changing the device's settings or replacing the leads. Unfortunately, current methods are slow and out-dated, and there is a real need to find new and improved ways of identifying devices during emergency settings. Our new software could be a solution, as it can identify devices accurately and instantly. This could help clinicians make the best decisions for treating patients."

More than 1 million people around the world undergo implantation of a cardiac rhythm device each year, with over 50,000 being implanted per year in the U.K. These devices are placed under the patients' skin to either help the heart's electrical system function properly or measure heart rhythm. Pacemakers treat slow heart rhythms by 'pacing' the heart to beat faster, while defibrillators treat fast heart rhythms by delivering electric shocks to reset the heartbeat back to a normal rhythm.

However, in some rare cases these devices can lose their ability to control the heartbeat, either because the device malfunctions or the wires connecting it to the heart move out of the correct position. When this happens, patients may experience palpitations, loss of consciousness or inappropriate electric shocks.

In these situations, clinicians need to determine the model of a device to investigate why it has failed. Unless they have access to the records where implantation took place, or the patient can tell them, staff must use a flowchart algorithm to identify pacemakers by a process of elimination. The flowchart contains a series of shapes and circuit board components of different pacemakers designed to help clinicians identify the make and model of a patient's pacemaker. Not only is this time-consuming, but these flow charts are now outdated and therefore inaccurate. This can result in delays to delivering care to patients, who are often in critical conditions.

In the new study, researchers trained the software program called a neural network to identify more than 1,600 different cardiac devices from patients.

To use the neural network, the clinician uploads the X-ray image containing the device into a computer and the software reads the image to give a result on the make and model of the device within seconds.

The team used the program to see if it could identify the devices from radiographic images of more than 1,500 patients at Hammersmith Hospital between 1998 and 2018. They then compared the results with five cardiologists who used the current flowchart algorithm to identify the devices.

The team found that the software outperformed current methods. It was 99 percent accurate in identifying the manufacturer of a device, compared with only 72 percent accuracy for the flow chart. The team suggests the software could greatly speed up the care of patients with heart rhythm device problems.

The researchers will aim to carry out a further trial to validate the results in a larger group of patients and investigate ways to create a more portable device that can be used on hospital wards.

For more information: www.electrophysiology.onlinejacc.org

Reference

1. Howard J.P., Fisher L., Shun-Shin M.J., et al. Cardiac Rhythm Device Identification Using Neural Networks. JACC: Clinical Electrophysiology, March 27, 2019. https://doi.org/10.1016/j.jacep.2019.02.003

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).